当前位置: 首页 >> 检索结果
共有 3634 条符合本次的查询结果, 用时 3.6133328 秒

3241. Colonic microbiota can promote rapid local improvement of murine colitis by thioguanine independently of T lymphocytes and host metabolism.

作者: I Oancea.;R Movva.;I Das.;D Aguirre de Cárcer.;V Schreiber.;Y Yang.;A Purdon.;B Harrington.;M Proctor.;R Wang.;Y Sheng.;M Lobb.;R Lourie.;P Ó Cuív.;J A Duley.;J Begun.;T H J Florin.
来源: Gut. 2017年66卷1期59-69页
Mercaptopurine (MP) and pro-drug azathioprine are 'first-line' oral therapies for maintaining remission in IBD. It is believed that their pharmacodynamic action is due to a slow cumulative decrease in activated lymphocytes homing to inflamed gut. We examined the role of host metabolism, lymphocytes and microbiome for the amelioration of colitis by the related thioguanine (TG).

3242. Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis.

作者: Sebastian Torben Jendrek.;Daniel Gotthardt.;Thomas Nitzsche.;Laila Widmann.;Tobias Korf.;Maike Anna Michaels.;Karl-Heinz Weiss.;Evaggelia Liaskou.;Mette Vesterhus.;Tom Hemming Karlsen.;Swantje Mindorf.;Peter Schemmer.;Florian Bär.;Bianca Teegen.;Torsten Schröder.;Marc Ehlers.;Christoph Matthias Hammers.;Lars Komorowski.;Hendrik Lehnert.;Klaus Fellermann.;Stefanie Derer.;Johannes Roksund Hov.;Christian Sina.
来源: Gut. 2017年66卷1期137-144页
Pancreatic autoantibodies (PABs), comprising antibodies against glycoprotein 2 (anti-GP2), are typically associated with complicated phenotypes in Crohn's disease, but have also been observed with variable frequencies in patients with UC. In a previous study, we observed a high frequency of primary sclerosing cholangitis (PSC) in patients with anti-GP2-positive UC. We therefore aimed to characterise the role of anti-GP2 in PSC.

3243. Erratum: Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis.

来源: Gut. 2016年65卷8期1394页

3244. Erratum: MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor.

来源: Gut. 2016年65卷8期1388页

3245. Primary sclerosing cholangitis: 50 years of a gut-liver relationship and still no love?

作者: Tom H Karlsen.
来源: Gut. 2016年65卷10期1579-81页

3246. Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer.

作者: Yaqing Zhang.;Ashley Velez-Delgado.;Esha Mathew.;Dongjun Li.;Flor M Mendez.;Kevin Flannagan.;Andrew D Rhim.;Diane M Simeone.;Gregory L Beatty.;Marina Pasca di Magliano.
来源: Gut. 2017年66卷1期124-136页
Pancreatic cancer is characterised by the accumulation of a fibro-inflammatory stroma. Within this stromal reaction, myeloid cells are a predominant population. Distinct myeloid subsets have been correlated with tumour promotion and unmasking of anti-tumour immunity.

3247. Diagnostic accuracy of the γ-glutamyl transpeptidase to platelet ratio to predict liver fibrosis in Egyptian patients with HCV genotype 4.

作者: Yusuke Shimakawa.;Philippe Bonnard.;Mohamed El Kassas.;Mohamed Abdel-Hamid.;Gamal Esmat.;Arnaud Fontanet.
来源: Gut. 2016年65卷9期1577-8页

3248. Fukuoka criteria accurately predict risk for adverse outcomes during follow-up of pancreatic cysts presumed to be intraductal papillary mucinous neoplasms.

作者: Saurabh Mukewar.;Nicolo de Pretis.;Anupama Aryal-Khanal.;Nazir Ahmed.;Raghuwansh Sah.;Felicity Enders.;Joseph J Larson.;Michael J Levy.;Naoki Takahashi.;Mark Topazian.;Randall Pearson.;Santhi S Vege.;Suresh T Chari.
来源: Gut. 2017年66卷10期1811-1817页
Fukuoka consensus guidelines classify pancreatic cystic lesions (PCLs) presumed to be intraductal papillary mucinous neoplasms (IPMNs) into Fukuoka positive (FP) (subgroups of high-risk (HR) and worrisome features (WFs)) and Fukuoka negative (FN) (non-HR feature/WF cysts). We retrospectively estimated 5-year risk of pancreatic cancer (PC) in FN, WF and HR cysts of patients with PCL-IPMN.

3249. Hemidesmosome integrity protects the colon against colitis and colorectal cancer.

作者: Adèle De Arcangelis.;Hussein Hamade.;Fabien Alpy.;Sylvain Normand.;Emilie Bruyère.;Olivier Lefebvre.;Agnès Méchine-Neuville.;Stéphanie Siebert.;Véronique Pfister.;Patricia Lepage.;Patrice Laquerriere.;Doulaye Dembele.;Anne Delanoye-Crespin.;Sophie Rodius.;Sylvie Robine.;Michèle Kedinger.;Isabelle Van Seuningen.;Patricia Simon-Assmann.;Mathias Chamaillard.;Michel Labouesse.;Elisabeth Georges-Labouesse.
来源: Gut. 2017年66卷10期1748-1760页
Epidemiological and clinical data indicate that patients suffering from IBD with long-standing colitis display a higher risk to develop colorectal high-grade dysplasia. Whereas carcinoma invasion and metastasis rely on basement membrane (BM) disruption, experimental evidence is lacking regarding the potential contribution of epithelial cell/BM anchorage on inflammation onset and subsequent neoplastic transformation of inflammatory lesions. Herein, we analyse the role of the α6β4 integrin receptor found in hemidesmosomes that attach intestinal epithelial cells (IECs) to the laminin-containing BM.

3250. A rare cause of colonic thickening and lymphadenopathy.

作者: Emma L Culver.;Lai Mun Wang.;Helen Bungay.;R W Chapman.;J Collier.
来源: Gut. 2017年66卷1期78页

3251. Human knockouts of PLA2G4A phenocopy NSAID-induced gastrointestinal and renal toxicity.

作者: Sateesh Maddirevula.;Mohammed Abanemai.;Fowzan S Alkuraya.
来源: Gut. 2016年65卷9期1575-7页

3252. Targeting cannabinoid receptors in hepatocellular carcinoma?

作者: Ariane Mallat.;Sophie Lotersztajn.
来源: Gut. 2016年65卷10期1582-3页

3253. When banding fails; investigation hails.

作者: F Arnold.;D Patch.;D Yu.;R H Westbrook.
来源: Gut. 2017年66卷2期322页

3254. High stability of faecal microbiome composition in guanidine thiocyanate solution at room temperature and robustness during colonoscopy.

作者: Yuichiro Nishimoto.;Sayaka Mizutani.;Takeshi Nakajima.;Fumie Hosoda.;Hikaru Watanabe.;Yutaka Saito.;Tatsuhiro Shibata.;Shinichi Yachida.;Takuji Yamada.
来源: Gut. 2016年65卷9期1574-5页

3255. Response to 'Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis' by Rühlemann et al.

作者: Martin Kummen.;Johannes R Hov.
来源: Gut. 2017年66卷4期755-756页

3256. Treatment of chronic hepatitis E with ribavirin: lessons from deep sequencing.

作者: Jérôme Gouttenoire.;Dagmara Szkolnicka.;Darius Moradpour.
来源: Gut. 2016年65卷10期1583-4页

3257. RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation.

作者: Helen H N Yan.;Jeffrey C W Lai.;Siu Lun Ho.;Wai Keung Leung.;Wai Lun Law.;Janet F Y Lee.;Anthony K W Chan.;Wai Yin Tsui.;Annie S Y Chan.;Bernard C H Lee.;Sarah S K Yue.;Alice H Y Man.;Hans Clevers.;Siu Tsan Yuen.;Suet Yi Leung.
来源: Gut. 2017年66卷9期1645-1656页
Serrated polyps (hyperplastic polyps, sessile or traditional serrated adenomas), which can arise in a sporadic or polyposis setting, predispose to colorectal cancer (CRC), especially those with microsatellite instability (MSI) due to MLH1 promoter methylation (MLH1me+). We investigate genetic alterations in the serrated polyposis pathway.

3258. GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer.

作者: Paola Martinelli.;Enrique Carrillo-de Santa Pau.;Trevor Cox.;Bruno Sainz.;Nelson Dusetti.;William Greenhalf.;Lorenzo Rinaldi.;Eithne Costello.;Paula Ghaneh.;Núria Malats.;Markus Büchler.;Marina Pajic.;Andrew V Biankin.;Juan Iovanna.;John Neoptolemos.;Francisco X Real.
来源: Gut. 2017年66卷9期1665-1676页
The role of GATA factors in cancer has gained increasing attention recently, but the function of GATA6 in pancreatic ductal adenocarcinoma (PDAC) is controversial. GATA6 is amplified in a subset of tumours and was proposed to be oncogenic, but high GATA6 levels are found in well-differentiated tumours and are associated with better patient outcome. By contrast, a tumour-suppressive function of GATA6 was demonstrated using genetic mouse models. We aimed at clarifying GATA6 function in PDAC.

3259. Guideline for obtaining valid consent for gastrointestinal endoscopy procedures.

作者: Simon M Everett.;Helen Griffiths.;U Nandasoma.;Katie Ayres.;Graham Bell.;Mike Cohen.;Siwan Thomas-Gibson.;Mike Thomson.;Kevin M T Naylor.
来源: Gut. 2016年65卷10期1585-601页
Much has changed since the last guideline of 2008, both in endoscopy and in the practice of obtaining informed consent, and it is vital that all endoscopists who are responsible for performing invasive and increasingly risky procedures are aware of the requirements for obtaining valid consent. This guideline is restricted to GI endoscopy but we cover elective and acute or emergency procedures. Few clinical trials have been carried out in relation to informed consent but most areas are informed by guidance from the General Medical Counsel (GMC) and/or are enshrined in legislation. Following an iterative voting process a series of recommendations have been drawn up that cover the majority of situations that will be encountered by endoscopists. This is not exhaustive and where doubt exists we have described where legal advice is likely to be required. This document relates to the law and endoscopy practice in the UK-where there is variation between the four devolved countries this is pointed out and endoscopists must be aware of the law where they practice. The recommendations are divided into consent for patients with and without capacity and we provide sections on provision of information and the consent process for patients in a variety of situations. This guideline is intended for use by all practitioners who request or perform GI endoscopy, or are involved in the pathway of such patients. If followed, we hope this document will enhance the experience of patients attending for endoscopy in UK units.

3260. The TRPA1 ion channel is expressed in CD4+ T cells and restrains T-cell-mediated colitis through inhibition of TRPV1.

作者: Samuel Bertin.;Yukari Aoki-Nonaka.;Jihyung Lee.;Petrus R de Jong.;Peter Kim.;Tiffany Han.;Timothy Yu.;Keith To.;Naoki Takahashi.;Brigid S Boland.;John T Chang.;Samuel B Ho.;Scott Herdman.;Maripat Corr.;Alessandra Franco.;Sonia Sharma.;Hui Dong.;Armen N Akopian.;Eyal Raz.
来源: Gut. 2017年66卷9期1584-1596页
Transient receptor potential ankyrin-1 (TRPA1) and transient receptor potential vanilloid-1 (TRPV1) are calcium (Ca2+)-permeable ion channels mostly known as pain receptors in sensory neurons. However, growing evidence suggests their crucial involvement in the pathogenesis of IBD. We explored the possible contribution of TRPA1 and TRPV1 to T-cell-mediated colitis.
共有 3634 条符合本次的查询结果, 用时 3.6133328 秒